Marium Husain

6PUBLICATIONS
41CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Correction: Tinoco et al. Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls. Cancers 2026, 18, 641.

|Feb 27, 2026
Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls.

Gabriel Tinoco, Marium Husain, David Liebner

|Jul 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors.

Caroline E Dravillas, Samuel S Coleman, Rebecca Hoyd

|Jan 23, 2024
A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset.

Cankun Wang, Anjun Ma, Yingjie Li

|Feb 04, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.

Andrew C Johns, Mike Yang, Lai Wei

|Nov 22, 2018
An overview of the unique challenges facing African-American breast cancer survivors.

Marium Husain, Timiya S Nolan, Kevin Foy

Pageof 1

Frequent Collaborators

4 joint publications

Gabriel Tinoco

3 joint publications

Daniel Spakowicz

3 joint publications

Rebecca Hoyd

2 joint publications

Yousef Zakharia